General Toxicology Services
Comprehensive General Toxicology Programs
A full suite of GLP and non-GLP general toxicology studies and services are provided by WuXi Biology and Testing, supported by the complementary capabilities of our DMPK, bioanalytical, and analytical service teams. This cross-functional knowledge provides not only the data you need, but insights into how it relates to your project goals.
By the Numbers
Square Feet of Lab Testing Space
Environmentally Controlled Animal Rooms
Safety Assessment Studies Conducted Per Year
Comprehensive General Toxicology Testing From IND to NDA
As a required step before first-in-human (FIH) studies, preclinical toxicology assessment is critical to the progression of your new drug candidate. We can accommodate GLP studies of varying size, length, and complexity, while providing for overall regulatory compliance. We can also customize a toxicology study to meet your specific needs. Your studies will be conducted in our state-of-the-art facility comprising environmentally controlled animal rooms and supporting workspace.
IND-enabling Toxicology Studies
For preclinical candidates (PCCs) or INDs, we provide bioanalytical method development and validation services in support of GLP toxicology studies to ensure a comprehensive safety assessment. If you have early-stage compounds, we recommend our Early Diagnosis Tests (EDT), which detect and eliminate potentially toxic drug candidates early on, saving critical time and costs. We can also reduce risk and costs by quickly screening libraries of candidate molecules, or by providing the unique PK/PD profile to assess the overall risk vs. benefit before moving forward.
NDA-enabling Toxicology Studies
One of the benefits of working with our integrated, global platform is the personalized, end-to-end support we’re able to provide for all your projects. For New Drug Application (NDA) submissions in particular, we can leverage the knowledge gained from working with your compound from the early stages of preclinical research to provide the best chance of success as you move through the clinical phases of development to market.
General Toxicology Services
We offer end-to-end testing programs that cover all your toxicology needs. This includes early-stage dose range finding studies that inform later-stage regulatory needs; single-dose acute toxicity testing to identify potential adverse effects of new drug candidates; and repeat-dose chronic toxicity studies for evaluating the effects of repeat administration over a defined period.
Our Core Service Capabilities Include
- Formulation analysis and bioanalysis (GLP and non-GLP)
- Early Diagnosis Testing (EDT)
- MTD and dose range finding (DRF)
- Single dose (acute toxicity)
- Repeat dose toxicity studies (IND-enabling, subchronic, and chronic)
Tested Species Capabilities
- Mice
- Rats
- Canines
- Cynomolgus and Rhesus non-human primates (NHPs)
- Swine
- Rabbits
Routes of Administration
- Intravenous (bolus and infusion)
- Oral (gavage and capsule) and nasogastric (for NHPs)
- Topical
- Intramuscular
- Subcutaneous
- Intradermal
- Ocular (including systemic, topical, subconjunctival, intravitreal, subretinal, and retrobulbar)
- Implant
- Intrathecal
- Intra-articular
- Intraperitoneal
- Intra-arterial
- Other routes available upon request
In-House Toxicologic Pathology Capabilities
- Clinical pathology (hematology, chemistry, coagulation and urinalysis)
- American College of Veterinary Pathologists (ACVP) and Chinese College of Veterinary Pathologist (CCVP) board-certified pathologists
- Necropsy (large capacity)
- Histopathology (trimming, embedding, sectioning and special staining)
- Immunohistochemistry (IHC) and Tissue Cross Reactivity (TCR)
- Immunopathology
General Toxicology Reporting
We leverage an automated reporting system to draft reports and maintain a dedicated study director group for report checking and peer-reviewing. Our team is committed to providing high-quality study data and delivering reports in a timely manner to meet your deadlines.
Explore Solutions for Your Program
Explore solutions by development phase, drug modality, therapeutic area, or integrated discovery needs.
Get a Quote
Ready to plan your next study? Share your program needs with our team for a tailored estimate.
General Toxicology FAQ
We offer a range of general toxicology services, including acute and chronic toxicity studies, dose-response assessments, genotoxicity evaluations, and organ-specific toxicity testing. Our services are designed to evaluate the safety and potential adverse effects of new compounds and products.
We adhere to strict quality management practices and follow GLP (Good Laboratory Practice) guidelines to ensure the accuracy and reliability of our studies. Our experienced team conducts thorough validation and calibration of equipment, rigorous data analysis, and comprehensive reporting to maintain high standards.
We utilize a variety of animal models, including rodents, rabbits, and non-human primates, depending on the study requirements and the nature of the compound being tested. Our choice of models is guided by regulatory standards and the specific needs of each study.
The timeline for completing a toxicology study varies based on the study's complexity and scope. Typically, acute toxicity studies may take a few weeks, while chronic or long-term studies can span several months. We provide estimated timelines during the planning phase of each project.
Yes, we provide comprehensive toxicology data and reports that are tailored to meet regulatory requirements for submissions to agencies such as the FDA, EMA, and other global regulatory bodies. Our data supports the development and approval processes for new drugs and chemicals.
We maintain strict confidentiality protocols to protect all sensitive and proprietary information. Access to study data is restricted to authorized personnel only, and we implement robust data security measures to safeguard your information throughout the study process.
To initiate a toxicology study, you can contact us to discuss your specific needs and objectives. We will collaborate with you to create the study design, provide a detailed proposal, and finalize the project plan. Once the study is underway, we keep you informed with regular updates and progress reports.
Yes, our toxicology services are highly customizable to address the unique requirements of each project. We work closely with clients to develop tailored study designs and protocols that align with their specific goals and regulatory requirements.
Dose range finding studies provide the first stage of toxicology assessments to select the proper doses for later regulatory studies. The studies are then used to determine doses for longer team studies to assess risks.
Single dose toxicity testing is used to determine potential adverse effects of new drug candidates and provide data for exposure. The data collected during these studies is used to design the dose levels for later repeat-dose, subchronic, and chronic toxicity studies.
The objective of repeat-dose toxicity studies is to evaluate adverse effects of compounds when administered repeatedly for a specific period. The length of a repeat-dose study can be 14 days, subchronic up to 3 months, or chronic longer than 3 months up to 2 years.



